SLC39A10 and gastric cancer: Indeed, our data demonstrated that SLC39A10 overexpression and knockdown led to a significant increase and decrease in CK2 activity in gastric cancer cells, respectively, and that this effect was effectively reversed by the Zn2+ chelator TPEN or CX-4945.